We are live on ! Find out more
GJIC

Gamble Jones Investment Counsel Portfolio holdings

AUM $1.33B
1-Year Est. Return 11.55%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
-11.55%
3 Year Est. Return
+32.88%
5 Year Est. Return
+72.75%
10 Year Est. Return
AUM
$918M
AUM Growth
+$17.9M
Cap. Flow
-$6.57M
Cap. Flow %
-0.72%
Top 10 Hldgs %
48.72%
Holding
210
New
7
Increased
65
Reduced
104
Closed
4

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.49M
2
DLTR icon
Dollar Tree
DLTR
+$2.16M
3
AAPL icon
Apple
AAPL
+$2.04M
4
PG icon
Procter & Gamble
PG
+$1.57M
5
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$1.24M

Sector Composition

Rank Sector Weight
1 Consumer Staples 37.54%
2 Healthcare 13.29%
3 Technology 9.66%
4 Industrials 9.01%
5 Financials 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
101
ConocoPhillips
COP
$153B
$1.4M 0.15%
32,070
-7,932
-20% -$350K
RTN
102
DELISTED
Raytheon Company
RTN
$1.39M 0.15%
10,221
+3
+0% +$391
DEO icon
103
Diageo
DEO
$52.2B
$1.35M 0.15%
11,989
-703
-6% -$76K
GS.PRB.CL
104
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
$1.26M 0.14%
47,550
GPC icon
105
Genuine Parts
GPC
$18.5B
$1.25M 0.14%
12,373
-76
-0.6% -$7.37K
DD
106
DELISTED
Du Pont De Nemours E I
DD
$1.24M 0.14%
19,181
-1,000
-5% -$65.7K
KHC icon
107
Kraft Heinz
KHC
$29.1B
$1.23M 0.13%
13,949
-177
-1% -$14.6K
CPB icon
108
Campbell Soup
CPB
$6.74B
$1.23M 0.13%
18,494
FAST icon
109
Fastenal
FAST
$59.9B
$1.17M 0.13%
105,320
+11,304
+12% +$129K
QQQ icon
110
Invesco QQQ Trust
QQQ
$481B
$1.16M 0.13%
10,809
-2,610
-19% -$282K
ORCL icon
111
Oracle
ORCL
$442B
$1.14M 0.12%
27,828
-1,043
-4% -$41.6K
DNOW icon
112
DNOW Inc
DNOW
$3.04B
$1.12M 0.12%
+61,893
New +$1.09M
LMT icon
113
Lockheed Martin
LMT
$140B
$1.12M 0.12%
4,524
-65
-1% -$15.3K
ZBH icon
114
Zimmer Biomet
ZBH
$18.7B
$1.11M 0.12%
9,522
DIA icon
115
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$1.1M 0.12%
6,162
+959
+18% +$170K
GSK icon
116
GSK
GSK
$101B
$1.1M 0.12%
20,362
-620
-3% -$32.7K
NOC icon
117
Northrop Grumman
NOC
$82B
$1.09M 0.12%
4,910
PAYX icon
118
Paychex
PAYX
$42.8B
$1.05M 0.11%
17,725
-822
-4% -$44K
MDT icon
119
Medtronic
MDT
$116B
$1.04M 0.11%
11,944
-254
-2% -$20.5K
GIS icon
120
General Mills
GIS
$20.4B
$1.02M 0.11%
14,363
-656
-4% -$41.8K
KMI icon
121
Kinder Morgan
KMI
$70.7B
$994K 0.11%
53,075
-34,365
-39% -$612K
QCOM icon
122
Qualcomm
QCOM
$171B
$962K 0.1%
17,960
-650
-3% -$34.3K
TGT icon
123
Target
TGT
$69.9B
$937K 0.1%
13,419
-6
-0% -$448
ECL icon
124
Ecolab
ECL
$78.1B
$898K 0.1%
7,575
-700
-8% -$81.6K
MUB icon
125
iShares National Muni Bond ETF
MUB
$45.9B
$896K 0.1%
7,866
+18
+0.2% +$2.03K

Similar funds

Gamble Jones Investment Counsel's Q2 2016 Portfolio in Review

As of Q2 2016, Gamble Jones Investment Counsel held 210 positions worth $918M, up 2% from $900M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Gamble Jones Investment Counsel's Q2 2016 filing shows 7 new, 65 increased, 104 reduced and 4 closed positions. Its largest new stake was SS&C Technologies: 57,912 shares worth $1.63M. The largest sale was AbbVie, an estimated $3.49M.

By sector, the portfolio is most concentrated in Consumer Staples at 38% of assets, up from 37% a quarter earlier, followed by Healthcare and Technology.

  • Gamble Jones Investment Counsel's largest Q2 2016 buy was SS&C Technologies: 57,912 shares worth $1.63M.
  • Gamble Jones Investment Counsel added most to Novartis in Q2 2016, an estimated $3.76M increase.
  • Gamble Jones Investment Counsel's biggest Q2 2016 reduction was AbbVie, cutting an estimated $3.49M.
  • Gamble Jones Investment Counsel fully exited Allergan Inc in Q2 2016, selling an estimated $348K.
  • Gamble Jones Investment Counsel's ten largest holdings make up 49% of its $918M portfolio in Q2 2016.
  • Gamble Jones Investment Counsel opened 7 new positions and closed 4 in Q2 2016.
  • Gamble Jones Investment Counsel's portfolio value rose 2% quarter-over-quarter to $918M.

Based on Gamble Jones Investment Counsel's 13F filing for Q2 2016, filed 9 Aug 2016.